Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.53 |
| ▸ | SELP | P16109 | 1/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.48 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.48 |
| ▸ | F3 | P13726 | 10/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17982560 | 1.00 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL21202083 | 1.00 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL18979864 | 1.00 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL19755906 | 0.97 | PTPN1 (0.50) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL24961200 | 0.96 | SELP (0.49) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL26711277 | 0.96 | SELP (0.49) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL19755909 | 0.95 | PTPN1 (0.53) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL2321885 | 0.93 | PTPN1 (0.59) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL18088365 | 0.93 | PTPN1 (0.59) | PTPN1SELPHSD11B1HSD11B2F3 | |
| SCHEMBL2321888 | 0.93 | PTPN1 (0.59) | PTPN1SELPHSD11B1HSD11B2F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4342305-A2 | METHODS FOR IMPROVING THE SOLUBILITY OF STEVIOL GLYCOSIDE MIXTURES, AND USES | The Coca-Cola Company (US) | 2024-03-27 | — | — | EP | disclosed |
| EP-3787417-B1 | METHODS FOR IMPROVING THE SOLUBILITY OF STEVIOL GLYCOSIDE MIXTURES, AND USES | COCA COLA CO (US) | 2024-02-28 | — | — | EP | disclosed |
| US-20220183334-A1 | Compositions and Methods for Improving Rebaudioside M Solubility | THE COCA-COLA COMPANY | 2022-06-16 | — | — | US | disclosed |
| US-11246936-B2 | Compositions and methods using rebaudioside X to provide sweetness enhancement | THE COCA-COLA COMPANY (US) | 2022-02-15 | — | — | US | disclosed |
| US-20210127726-A1 | METHODS FOR IMPROVING THE SOLUBILITY OF STEVIOL GLYCOSIDE MIXTURES, AND USES | THE COCA-COLA COMPANY | 2021-05-06 | — | — | US | disclosed |
| US-20210115081-A1 | PROCESS FOR PREPARING CONCENTRATED SOLUTIONS OF STEVIOL GLYCOSIDES, AND USES | THE COCA-COLA COMPANY | 2021-04-22 | — | — | US | disclosed |
| EP-3019198-B1 | COMPOSITIONS AND METHODS FOR IMPROVING REBAUDIOSIDE M SOLUBILITY | COCA COLA CO (US) | 2021-02-17 | — | — | EP | disclosed |
| US-20210007381-A1 | CONCENTRATES COMPRISING STEVIA BLENDS AND USES | THE COCA-COLA COMPANY | 2021-01-14 | — | — | US | disclosed |
| US-10849339-B2 | Beverages containing rare sugars | THE COCA-COLA COMPANY (US) | 2020-12-01 | — | — | US | disclosed |
| US-20200315227-A1 | Process for Preparing Concentrated Solutions of Steviol Glycosides and Mogrosides, and Uses | THE COCA-COLA COMPANY | 2020-10-08 | — | — | US | disclosed |
| US-20200178587-A1 | Methods of Freeze Drying Compositions Containing Rebaudioside M and Rebaudioside D | THE COCA-COLA COMPANY | 2020-06-11 | — | — | US | disclosed |
| EP-2993990-B1 | BEVERAGES CONTAINING RARE SUGARS | COCA COLA CO (US) | 2019-11-13 | — | — | EP | disclosed |
| EP-3019197-B1 | REBAUDIOSIDE X TO PROVIDE SWEETNESS ENHANCEMENT | COCA COLA CO (US) | 2019-08-28 | — | — | EP | disclosed |
| US-20190230956-A1 | Beverages Containing Rare Sugars | THE COCA-COLA COMPANY | 2019-08-01 | — | — | US | disclosed |
| US-20180296678-A1 | Compositions and Methods Using Rebaudioside X to Provide Sweetness Enhancement | THE COCA-COLA COMPANY | 2018-10-18 | — | — | US | disclosed |
| EP-2793618-B1 | BEVERAGE COMPRISING STEVIOL GLYCOSIDES | COCA COLA CO (US) | 2017-11-15 | — | — | EP | disclosed |
| US-20170295827-A1 | BEVERAGES CONTAINING RARE SUGARS | THE COCA-COLA COMPANY | 2017-10-19 | — | — | US | disclosed |
| US-20170172191-A1 | Compositions and Methods for Improving Rebaudioside M Solubility | PURECIRCLE SDN BHD (MY) | 2017-06-22 | — | — | US | disclosed |
| US-20140272068-A1 | BEVERAGES CONTAINING RARE SUGARS | THE COCA-COLA COMPANY | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115081-A1 | PROCESS FOR PREPARING CONCENTRATED SOLUTIONS OF STEVIOL GLYCOSIDES, AND USES | SORD, SI, SBDS | PTPN1 2843/4885SELP 347/4885HSD11B1 90/4885 |
| US-20180296678-A1 | Compositions and Methods Using Rebaudioside X to Provide Sweetness Enhancement | RDX, PDE8A, GPR119 | PTPN1 2989/4885SELP 3784/4885HSD11B1 2949/4885 |
| US-11246936-B2 | Compositions and methods using rebaudioside X to provide sweetness enhancement | RDX, PDE8A, GPR119 | PTPN1 2989/4885SELP 3784/4885HSD11B1 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.